This compound is a salt or multi-component mixture used as a pharmaceutical intermediate. Its structure includes both a quinoline-containing fragment and a phosphorylated ester fragment, indicating a role in the synthesis of complex organic molecules for research or manufacturing purposes.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 137590-32-0
Tert-Butyl N-(2,3-dihydroxypropyl)carbamate
Pharmaceutical intermediate for peptide synthesis
3-bromo-5-chloropyridin-2-ol
Pharmaceutical intermediate
6-Chloro-N-(4-fluorophenyl)picolinamide
pharmaceutical intermediate
N-acetyl-S-(1-carbamoyl-2-hydroxyethyl)-l-cysteine
pharmaceutical reference standard
((2-Methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl) acetic acid
pharmaceutical intermediate
(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-quinolin-4-ylmethanol;2-[[(1R)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetic acid
AMCLPZVIVCCLMU-ZCIVCQFFSA-N
CCC(=O)O[C@@H](C(C)C)O[P@@](=O)(CCCCC1=CC=CC=C1)CC(=O)O.C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@@H](C3=CC=NC4=CC=CC=C34)O
—